Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Darbepoetin-alpha and i.v. iron administration after autologous hematopoietic stem cell
transplantation for hematological malignancies : a prospective randomized trial.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University Hospital of Liege University of Liege
Collaborators:
Amgen Katholieke Universiteit Leuven KU Leuven Vrije Universiteit Brussel
Treatments:
Darbepoetin alfa Epoetin Alfa Ferric Compounds Ferric Oxide, Saccharated Iron